The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
RETRACTED ARTICLE: A mechanism for the suppression of homologous recombination in G1 cells
Open accessAbstract
DNA repair by homologous recombination is highly suppressed in G1 cells to ensure that mitotic recombination occurs solely between sister chromatids. Although many homologous recombination factors are cell-cycle regulated, the identity of the events that are both necessary and sufficient to suppress recombination in G1 cells is unknown. Here we report that the cell cycle controls the interaction of BRCA1 with PALB2-BRCA2 to constrain BRCA2 function to the S/G2 phases in human cells. We found that the BRCA1-interaction site on PALB2 is targeted by an E3 ubiquitin ligase composed of KEAP1, a PALB2-interacting protein, in complex with cullin-3 (CUL3)-RBX1 (ref. 6). PALB2 ubiquitylation suppresses its interaction with BRCA1 and is counteracted by the deubiquitylase USP11, which is itself under cell cycle control. Restoration of the BRCA1-PALB2 interaction combined with the activation of DNA-end resection is sufficient to induce homologous recombination in G1, as measured by RAD51 recruitment, unscheduled DNA synthesis and a CRISPR-Cas9-based gene-targeting assay. We conclude that the mechanism prohibiting homologous recombination in G1 minimally consists of the suppression of DNA-end resection coupled with a multi-step block of the recruitment of BRCA2 to DNA damage sites that involves the inhibition of BRCA1-PALB2-BRCA2 complex assembly. We speculate that the ability to induce homologous recombination in G1 cells with defined factors could spur the development of gene-targeting applications in non-dividing cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“because it is only readily available in dividing cells [110,111]”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [111]
In the citing paper
“Non-mitotic cells are very inefficient for HDR-based repair, which is the main pathway to correct genetic disorders to date [87, 200].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions
Orthwein, A., Fradet‐Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano‐Diaz, C., & Durocher, D. (2014) · Science · doi:10.1126/science.1248024 · Cited by 332
Self-citationRetractedGenome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3181 · Cited by 1,555
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,523
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle
Rothkamm, K., Krüger, I., Thompson, L. H., & Lübrich, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5706-5715.2003 · Cited by 1,187
Repair of Strand Breaks by Homologous RecombinationPreprint
Jasin, M., & Rothstein, R. J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012740 · Cited by 929
Escribano‐Diaz, C., Orthwein, A., Fradet‐Turcotte, A., Xing, M., Young, J. T. F., Tkáč, J., Cook, M. A., Rosebrock, A. P., Munro, M., Canny, M. D., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.001 · Cited by 903
Self-citationControl of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Self-citation
Cited by
Sorted by citations
Items 301–400 of 462
DNA End Joining: G0-ing to the Core
Frock, R. L., Sadeghi, C., Meng, J., & Wang, J. (2021) · Biomolecules · doi:10.3390/biom11101487 · Cited by 16
Maurer, S. K., Mayer, M. P., Ward, S. J., Boudjema, S., Halawa, M. R., Zhang, J., Caulton, S. G., Emsley, J., & Dreveny, I. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105300 · Cited by 16
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Zhou, Y., Zhang, Q., Zhao, Z., Hu, X., You, Q., & Jiang, Z. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116270 · Cited by 15
Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
McDonald, A. J., & Wijnholds, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052887 · Cited by 16
Inhibitors of DNA double-strand break repair at the crossroads of cancer therapy and genome editing
Ray, U., & Raghavan, S. C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114195 · Cited by 14
Enhancement of CRISPR-Cas9 induced precise gene editing by targeting histone H2A-K15 ubiquitination
Bashir, S., Dang, T., Rossius, J., Wolf, J., & Kühn, R. (2020) · BMC Biotechnology · doi:10.1186/s12896-020-00650-x · Cited by 14
Post-translational modification of factors involved in homologous recombination
Argunhan, B., Iwasaki, H., & Tsubouchi, H. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103114 · Cited by 15
Tang, Y., Yuan, Q., Zhao, C., Xu, Y., Zhang, Q., Wang, L., Sun, Z., Cao, J., Luo, J., & Jiao, Y. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.1998711 · Cited by 14
RIF1 Links Replication Timing with Fork Reactivation and DNA Double-Strand Break Repair
Błasiak, J., Szczepańska, J., Sobczuk, A., Fila, M., & Pawłowska, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111440 · Cited by 16
PCNA-Ub polyubiquitination inhibits cell proliferation and induces cell-cycle checkpoints
Qin, Z., Bai, Z., Sun, Y. J., Niu, X., & Xiao, W. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1245247 · Cited by 16
Petibone, D. M., Mustafa, T. A., Bourdo, S. E., Lafont, A., Ding, W., Karmakar, A., Nima, Z. A., Watanabe, F., Casciano, D. A., Morris, S. M., et al. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3472 · Cited by 14
Modulation of proteasome activity by curcumin and didemethylcurcumin
Khan, T. K., You, Y., Nelson, T. J., Kundu, S., Pramanik, S. K., & Das, J. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1911853 · Cited by 14
The roles of KLHL family members in human cancers.
Ye, G., Wang, J., Yang, W., Li, J., Meng, Y., & Jin, X. (2022) · PubMed Central · Cited by 13
Exploring factors influencing choice of DNA double-strand break repair pathways
Otarbayev, D., & Myung, K. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103696 · Cited by 14
Benitez, E. K., Lomova, A., Cervantes, L., Clark, D. N., Ayoub, P. G., Senadheera, S., Osborne, K. S., Sanchez, J. M., Crisostomo, R. V., Wang, X., et al. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.601541 · Cited by 13
Anglada, T., Genescà, A., & Martı́n, M. (2020) · Aging · doi:10.18632/aging.202419 · Cited by 14
Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application
Kratzer, K., Getz, L. J., Peterlini, T., Masson, J., & Dellaire, G. (2021) · Human Genetics · doi:10.1007/s00439-021-02272-5 · Cited by 14
Self-citationLee, A. B. C., Tan, M. H., & Chai, C. L. L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.006 · Cited by 13
Ubiquitin E3 ligases in cancer: somatic mutation and amplification
Jo, E.-H., Kim, M., Lee, H.-J., & Park, H.-S. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0037 · Cited by 12
Hu, C., Bugbee, T., Dacus, D., Palinski, R. M., & Wallace, N. A. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010275 · Cited by 13
Galanti, L., Peritore, M., Gnügge, R., Cannavò, E., Heipke, J., Palumbieri, M. D., Steigenberger, B. A., Symington, L. S., Ćejka, P., & Pfander, B. (2024) · Nature Communications · doi:10.1038/s41467-024-46951-z · Cited by 14
Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12
Ingersoll, A. J., McCloud, D. M., Hu, J. G., & Rapé, M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116262 · Cited by 11
Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase
O'Dea, R., & Santocanale, C. (2020) · Journal of Cell Science · doi:10.1242/jcs.233437 · Cited by 11
Gnedina, O. O., Morshneva, A. V., Skvortsova, E. V., & Igotti, M. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073517 · Cited by 11
Li, F., Mladenov, E., Broich, A., Soni, A., Stuschke, M., Timmermann, B., & Iliakis, G. E. (2023) · Cells · doi:10.3390/cells12111530 · Cited by 11
Dissecting the Keap1/Nrf2 pathway through proteomics
Tamir, T. Y., Mulvaney, K. M., & Major, M. B. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.007 · Cited by 11
Sharpening the ends for repair: mechanisms and regulation of DNA resection
Paudyal, S. C., & You, Z. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw043 · Cited by 14
DoUBLing up: ubiquitin and ubiquitin-like proteases in genome stability
Foster, B. M., Wang, Z., & Schmidt, C. K. (2024) · Biochemical Journal · doi:10.1042/bcj20230284 · Cited by 10
Unraveling of Central Nervous System Disease Mechanisms Using CRISPR Genome Manipulation
Vesikansa, A. (2018) · Journal of Central Nervous System Disease · doi:10.1177/1179573518787469 · Cited by 10
BRCA1: a key player at multiple stages of homologous recombination in DNA double-strand break repair
Liu, Y., & Lu, L. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00042-1 · Cited by 11
Beta human papillomavirus 8E6 promotes alternative end joining
Hu, C., Bugbee, T., Palinski, R. M., Akinyemi, I. A., McIntosh, M. T., MacCarthy, T., Bhaduri‐McIntosh, S., & Wallace, N. A. (2023) · eLife · doi:10.7554/elife.81923 · Cited by 10
Liu, C., Fang, J., Kang, W., Yang, Y., Yu, C., Chen, H., Zhang, Y., & Ouyang, H. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2293594 · Cited by 10
Balancing act: To be, or not to be ubiquitylated
Nishi, R. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.07.006 · Cited by 10
A meeting at risk: Unrepaired DSBs go for broke
Guénolé, A., & Legube, G. (2017) · Nucleus · doi:10.1080/19491034.2017.1380138 · Cited by 14
Subbarayan, R., Srinivasan, D., Balakrishnan, R., Kumar, A., Usmani, S. S., & Srivastava, N. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.05.001 · Cited by 9
Lv, W., Wang, H., Peng, J., Wang, Y., Jiang, J., & Li, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21136 · Cited by 9
Burns, V. E., & Kerppola, T. K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100355 · Cited by 9
Pharmacological methods to transcriptionally modulate double-strand break DNA repair
Kaplan, A. R., & Glazer, P. M. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.11.003 · Cited by 9
RNA polymerase III directly participates in DNA homologous recombination
Liu, S., Li, X., Liu, X., Wang, J., Li, L., & Kong, D. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.06.007 · Cited by 8
Gross Chromosomal Rearrangement at Centromeres
Xu, R., Pan, Z., & Nakagawa, T. (2023) · Biomolecules · doi:10.3390/biom14010028 · Cited by 8
Chen, J., Su, S., Pickar‐Oliver, A., Chiarella, A. M., Hahn, Q., Goldfarb, D., Cloer, E. W., Small, G. W., Sivashankar, S., Ramsden, D. A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae761 · Cited by 8
Emerging cellular and gene therapies for congenital anemias
Ludwig, L. S., Khajuria, R. K., & Sankaran, V. G. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31529 · Cited by 9
Eukaryotic DNA damage responses: Homologous recombination factors and ubiquitin modification
Lee, N. S., Kim, S.-M., Jung, Y. W., & Kim, H. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.04.003 · Cited by 10
Fournier, M. L., Rodrigue, A., Milano, L., Bleuyard, J., Couturier, A. M., Wall, J., Ellins, J., Hester, S., Smerdon, S. J., Tora, L., et al. (2022) · eLife · doi:10.7554/elife.57736 · Cited by 8
Cell Cycle–Mediated Regulation of Secondary Ig Diversification
Bello, A., Müller, A., Hirth, G., Giebeler, L. N., Böttcher, K., Voigt, S., & Jungnickel, B. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2100880 · Cited by 8
Targeting homologous recombination repair in cancer
Murfuni, I., & Rass, U. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00008-5 · Cited by 8
Ubiquitin and the DNA double-strand break repair pathway
Nowsheen, S., Deng, M., & Lou, Z. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00007-5 · Cited by 8
Antagonistic relationship of NuA4 with the non-homologous end-joining machinery at DNA damage sites
Ahmad, S., Côté, V., Cheng, X., Bourriquen, G., Sapountzi, V., Altaf, M., & Côté, J. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009816 · Cited by 7
Gene Therapy for Paediatric Homozygous Familial Hypercholesterolaemia
Graves, L. E., Horton, A., Alexander, I. E., & Srinivasan, S. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.01.017 · Cited by 7
Yuen, S. C., Lee, S. M., & Leung, S.-W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215349 · Cited by 7
Bazinet, A., Heath, J., Chong, A., Simo‐Cheyou, E. R., Worme, S. J., Rivera, B., Foulkes, W. D., Caplan, S. N., Johnson, N. A., Orthwein, A., et al. (2021) · Molecular Case Studies · doi:10.1101/mcs.a006090 · Cited by 7
Self-citationWang, Z., Jin, M., Zhai, L., Huang, B., Jin, X., Wang, X., Boudemia, A. E., Yang, X., Wei, Z., He, Y., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.01.020 · Cited by 6
MDM2 antagonists promote CRISPR/Cas9-mediated precise genome editing in sheep primary cells
Li, Y., Lian, D., Wang, J., Zhao, Y., Li, Y., Liu, G., Wu, S., Deng, S., Du, X., & Lian, Z. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.12.020 · Cited by 6
He, X., Chen, W., Liu, Z., Yu, G., Chen, Y., Cai, Y., Sun, L., Xu, W., Zhong, L., Gao, C., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa195 · Cited by 6
De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer
Bernstein‐Molho, R., Zalmanoviz, S., Laitman, Y., & Friedman, E. (2019) · Familial Cancer · doi:10.1007/s10689-019-00157-1 · Cited by 6
Yu, N., Qin, H., Zhang, F., Liu, T., Cao, K., Yang, Y., Chen, Y., & Cai, J. (2022) · The Journal of Gene Medicine · doi:10.1002/jgm.3470 · Cited by 7
Genome editing for blood disorders: state of the art and recent advances
Romito, M., Rai, R., Thrasher, A. J., & Cavazza, A. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180147 · Cited by 7
PALB2 and 53BP1 govern post-resection homologous recombination DNA repair
Wang, Y., Coulombe, Y., Yueh, W.-T., Conway, G. D., Milano, L., Glass, D. J., Thomas, M. L., Rodrigue, A., Nacson, J., Lu, D., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.003 · Cited by 5
Self-citationInsight into meiotic DNA end resection: Mechanisms and regulation
Kim, S., Alnaser, H. F., Keeney, S., & Murakami, H. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103886 · Cited by 5
Tao, Q., Bai, F., Zhang, S., Xu, Y., Wang, Y., Yuan, S., Liu, X., Du, Y., Peng, B., Zhu, W., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107768 · Cited by 5
Maruta, G., MAEOKA, H., Tsunoda, T., Akiyoshi, K., Takagi, S., Shirasawa, S., & Ishikura, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae852 · Cited by 5
Jung, E. S., Kim, J. H., Chang, M., Hong, W., Quan, Z., Kim, S. H., You, S., Kim, D., Jang, J., Lee, S., et al. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102664 · Cited by 5
PALB2 as a factor to predict the prognosis of patients with skull base chordoma
Xiong, Y., Li, M., Shen, Y., Ma, T., Bai, J., & Zhang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.996892 · Cited by 5
DNA strand breaks at centromeres: Friend or foe?
Graham, E., & Esashi, F. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.10.004 · Cited by 5
Enikanolaiye, A., Ruston, J., Zeng, R., Taylor, C., Schrock, M., Buchovecky, C. M., Shendure, J., Acar, E. F., & Justice, M. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/810929 · Cited by 5
Genetic therapies for neurological diseases
Rahim, A. A., Kurian, M. A., Zhou, H., Ferguson, R., Tabrizi, S. J., Lignani, G., Aquilina, K., & Waddington, S. N. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100093 · Cited by 4
Graves, L. E., Viswanath, L., van Dijk, E. B., Zhu, E., Koyyalamudi, S. R., Wotton, T., Rosser, S. P. A., Srinivasan, S., Ginn, S. L., & Alexander, I. E. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.011 · Cited by 4
Natsagdorj, M., Hara, H., Uosaki, H., Nakahara, F., Inoue, M., & Hanazono, Y. (2026) · Communications Biology · doi:10.1038/s42003-026-09604-z · Cited by 4
Protein oxidation increases SAMHD1 binding ssDNA via its regulatory site
Simermeyer, T. L., Batalis, S., Rogers, L. C., Zalesak, O. J., & Hollis, T. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad447 · Cited by 4
Liu, P., Zhuo, Z., Xie, F., Wang, S., & Zhao, X. T. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.010 · Cited by 4
USP11 suppresses CHK1 activation by deubiquitinating CLASPIN
Zhao, H., Wang, Z., Zhu, M., Liao, J., & Xu, X. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00034-1 · Cited by 4
Brnich, S. E., Arteaga, E. C., Wang, Y., Tan, X. M., & Berg, J. S. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.04.010 · Cited by 4
Barabino, S. M. L., Citterio, E., & Ronchi, A. E. (2021) · Cancers · doi:10.3390/cancers13153753 · Cited by 4
Hovland, H. N., Mchaina, E. K., Høberg‐Vetti, H., Ariansen, S. L., Sjursen, W., Ghelue, M. V., Haukanes, B. I., Knappskog, P. M., Aukrust, I., & Ognedal, E. (2023) · Genes · doi:10.3390/genes14020262 · Cited by 4
The cell cycle flavours of repair
Zlotorynski, E. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.24 · Cited by 4
Tennant, P. A., Foster, R. G., Dodd, D. O., Sou, I. F., McPhie, F., Younger, N. T., Murphy, L. C., Pearson, M. W., Vernay, B., Keighren, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.14.200170 · Cited by 4
Chen, R.-D., Yang, Y., Liu, K.-M., Hu, J.-Z., Feng, Y.-L., Yang, C., Jiang, R.-R., Liu, S.-C., Wang, Y., Han, P.-A., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03567-w · Cited by 4
Advances in the relationship of immune checkpoint inhibitors and DNA damage repair
Liu, X., Wang, S., Lv, H., Chen, E., Yan, L., & Yu, J. (2025) · Current Research in Translational Medicine · doi:10.1016/j.retram.2025.103494 · Cited by 3
Kovač, A., Miskey, C., & Ivics, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914978 · Cited by 3
Jang, S., Shin, S., Jeong, Y., & Lim, D. (2023) · Organoid · doi:10.51335/organoid.2023.3.e16 · Cited by 3
Applications of CRISPR-Cas in Ageing Research
Haston, S., Pozzi, S., & González-Meljem, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_11 · Cited by 3
The immediate-early protein 1 of human herpesvirus 6B interacts with NBS1 and inhibits ATM signaling
Collin, V., Biquand, É., Tremblay, V., Lavoie, É. G., Blondeau, A., Gravel, A., Galloy, M., Lashgari, A., Dessapt, J., Côté, J., et al. (2024) · EMBO Reports · doi:10.1038/s44319-023-00035-z · Cited by 3
Lumbar discectomy: developing and implementing a day surgery protocol.
Doerksen, K., & Dusik-Sharpe, J. (2003) · PubMed · Cited by 3
Processes that Regulate the Ubiquitination of Chromatin and Chromatin-Associated Proteins
Hare, A. E., & Parvin, J. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82567 · Cited by 3
Ubiquitin-specific proteases as targets for anticancer drug therapies
Campos-Iglesias, D., López-Otín, C., & Freije, J. M. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818168-3.00004-8 · Cited by 4
A genetically encoded inhibitor of 53BP1 to stimulate homology-based gene editingPreprint
Canny, M. D., Wan, L. C. K., Fradet‐Turcotte, A., Orthwein, A., Moatti, N., Juang, Y.-C. A., Zhang, W., Noordermeer, S. M., Wilson, M. D., Vorobyov, A., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060954 · Cited by 3
Self-citationNonhomologous end joining—the importance of end tethering and beyondPreprint
Zha, S., & Yi, G. (2026) · Genes & Development · doi:10.1101/gad.353407.125 · Cited by 5
Zhao, C., Cao, Y., Ibrahim, N., Wang, Y., & Martemyanov, K. A. (2025) · Nature Communications · doi:10.1038/s41467-025-58945-6 · Cited by 2
Structural basis of CSN-mediated SCF deneddylation
Ding, S., Clapperton, J. A., Mäeots, M.-E., Kunzelmann, S., Shaaban, M., & Enchev, R. I. (2026) · Nature Communications · doi:10.1038/s41467-025-67566-y · Cited by 2
Self-citationAltered cell cycle regulation in the development of resistance
Alves, R., Jorge, J., Lapa, B., Ribeiro, I. P., Teles, P., Nobre-Góis, I., Santos, L., Gomes, C. M. F., Sarmento‐Ribeiro, A. B., & Gonçalves, A. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21790-6.00005-5 · Cited by 2
BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications
Valarmathi, M. T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100842 · Cited by 2
Delivering Base Editors In Vivo by Adeno-Associated Virus Vectors
Lim, C. K. W., Miskalis, A., Pérez‐Piñera, P., & Gaj, T. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2879-9_11 · Cited by 2
Cell-cycle dependent inhibition of BRCA1 signaling by the lysine methyltransferase SET8
Perez, Y., Alhourani, F., Patouillard, J., Ribeyre, C., Larroque, M., Baldin, V., Llères, D., Grimaud, C., & Julien, E. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2508114 · Cited by 2
The cell cycle flavours of repair
Zlotorynski, E. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.35 · Cited by 2
Recent Advances in In Vivo Genome Editing Targeting Mammalian Preimplantation Embryos
Sato, M., Ohtsuka, M., Inada, E., Nakamura, S., Saitoh, I., & Takabayashi, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106873 · Cited by 2
Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein
Thouvenot, P., Fourrière, L., Dardillac, E., Yamin, B. B., Lescure, A., Lejour, V., Heiligenstein, X., Boulé, J.-B., Romao, M., Raposo, G., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.192880 · Cited by 2
Khan, S., Carpenter, M. A., & Kemp, M. G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.20.508657 · Cited by 3
Engineering recombination machinery facilitates the construction of yeast cell factories
Jia, N., Zhou, Y. J., & Gao, J. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf066 · Cited by 1
Pal, D., & Summers, M. K. (2018) · InTech eBooks · doi:10.5772/intechopen.70482 · Cited by 2
Metadata
- Authors
- Orthwein, A., Noordermeer, S. M., Wilson, M. D., Landry, S., Enchev, R. I., Sherker, A., Munro, M., Pinder, J., Salsman, J., Dellaire, G., Xia, B., Peter, M., & Durocher, D.
- Affiliations
- Mount Sinai Hospital (CA)
- ETH Zurich (CH)
- Dalhousie University (CA)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Durocher, Daniel
- ORCID
- Venue
- Nature
- Published
- 2015-12-09
- Volume
- 528
- Issue
- 7582
- Pages
- 422-426
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4880051
- OpenAlex
- W2202899490
- Cited by
- 471
- References
- 39
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 26 · 2023: 35 · 2022: 36 · 2021: 52 · 2020: 61 · 2019: 64 · 2018: 52 · 2017: 67 · 2016: 54 · 2015: 1
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2025-01-27)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Centers for Disease Control and Prevention
- Canadian Institutes of Health Research (FDN143343 (, MOP84260)
- National Cancer Institute (R01CA138804)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- homologous recombination, G1 cell cycle, BRCA1, PALB2, BRCA2, DNA end resection, cell cycle regulation, Keap1, CUL3, RBX1, USP11, ubiquitination, sister chromatid recombination, DNA repair, CRISPR/Cas9
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Fanconi Anemia Complementation Group N Protein, Amino Acid Sequence, Carrier Proteins, Cell Line, DNA, DNA Damage, DNA Repair, Humans, Molecular Sequence Data, Nuclear Proteins, Protein Binding, Thiolester Hydrolases, G1 Phase, G2 Phase, S Phase, Gene Targeting, BRCA1 Protein, BRCA2 Protein, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Cullin Proteins, Multiprotein Complexes, Intracellular Signaling Peptides and Proteins, Rad51 Recombinase, Ubiquitination, Homologous Recombination, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review